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Abstract: Background: Depressed patients have an increased risk of myocardial infarction, for which
acute stress is a frequent trigger. Prothrombotic changes could be one involved mechanism that can be
modulated by psychological coping. Purpose: We examined the effects of remitted major depression and
situation-specific coping strategies on stress-induced coagulation activation. Methods: Forty patients with
remitted depression and 23 healthy controls underwent the Trier Social Stress Test, rating applied coping
strategies thereafter. Blood was sampled at baseline and 15 and 45 min poststress to measure fibrinogen,
von Willebrand factor (VWF) and D-dimer. Coagulation activation over time was quantified as area
under the curve (AUC) with respect to baseline activity. Standardized z-scores of individual coagulation
AUC measures were added up to a prothrombotic index. Results: Stress provoked significant VWF (p
= .024) and D-dimer (p = .002) responses. Remitted depressed patients used positive distraction coping
more frequently than controls did (p = .030). Coagulation AUC measures were similar in both groups.
In all participants, higher positive coping total (p = 0.009), driven by devaluation/defense (p = .022) and
distraction (p = .004) coping, was associated with a lower prothrombotic index. In controls, but not in
remitted depressed patients, higher positive coping total (p = .008), driven by higher devaluation/defense
(p = .010) and distraction (p = .023) coping, was associated with lower VWF AUC. Conclusions: Despite
the use of favorable coping strategies in a specific stress situation, remitted depressed patients may benefit
less from a positive effect of positive situational coping on coagulation activation than controls. Such a
mechanism could partially explain the increased risk of myocardial infarction in depressed individuals.
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Background: Depressed patients have an increased risk of myocardial infarction, for 
which acute stress is a frequent trigger. Prothrombotic changes are one involved mechanism, 
which can be modulated by psychological coping. 
Purpose: We examined the effects of remitted major depression and situation-specific 
coping strategies on stress-induced coagulation activation. 
Methods: 40 remitted depressed patients and 23 healthy controls underwent the Trier 
Social Stress Test, rating applied coping strategies thereafter. Blood was sampled at baseline, 
15 min and 45 min post-stress to measure fibrinogen, von Willebrand factor (VWF) and D-dimer. 
Coagulation activation over time was quantified as area under the curve (AUC) with respect to 
baseline activity. Standardized z-scores of individual coagulation AUC measures were added up to 
a prothrombotic index. 
Results: Stress provoked significant VWF (p=0.024) and D-dimer (p=0.002) responses. 
Remitted depressed patients used positive distraction coping more frequently than controls did 
(p=0.030). Coagulation AUC measures were similar in both groups. In all participants, higher 
positive coping total (p=0.009), driven by devaluation/defense (p=0.022) and distraction (p=0.004) 
coping, was associated with a lower prothrombotic index. In controls, but not in remitted 
depressed patients, higher positive coping total (p=0.008), driven by higher devaluation/defense 
(p=0.010) and distraction (p=0.023) coping, was associated with lower VWF AUC.  
Conclusions: Despite the use of favorable coping strategies in a specific stress 
situation, remitted depressed patients may benefit less from a positive effect of positive situational 
coping on coagulation activation than controls. Such a mechanism could partially explain the 
increased risk of myocardial infarction in depressed individuals. 
 




Major depressive disorder (MDD) is associated with a 1.3-fold increased risk of 
incident myocardial infarction (MI) and coronary death (1). Minor symptoms of depression 
have also been associated with an excess risk of MI, independent of sociodemographic and 
traditional cardiovascular risk factors (2, 3). Between 10% and 20% of patients report an 
emotional trigger within 1-2 hours of MI onset (4, 5), with, for instance, acute depressed 
mood quadrupling the risk (6). Individuals with subclinical atherosclerosis, prevalent in 
depression, are particularly vulnerable to mental triggering of MI (7, 8). Several biological 
mechanisms are involved in mental triggering of MI. Activation of the sympathetic nervous 
system (SNS) results in increased myocardial oxygen demand, vasoconstriction, 
hemodynamic shear forces to a vulnerable atherosclerotic plaque, and proinflammatory and 
procoagulant changes (9, 10). Regarding the latter, thrombotic occlusion following plaque  
rupture marks the transition from subclinical atherosclerosis to acute MI (11). This is 
especially true when excessive coagulation activation occurs beyond a physiologic 
procoagulant response to stress, the purpose of which is to protect a healthy organism from 
too much blood loss in fight-flight situations (10). 
Depression has been shown to be a modulator of stress-induced coagulation activation 
and post-stress recovery (10). For instance, in older dementia caregivers, depressed mood 
was associated with increased stress-induced platelet activation and delayed recovery of 
platelet activity post-stress (12). In middle-aged adults, depressed mood was also associated 
with a stress-induced increase in plasma levels of von Willebrand factor (VWF), mediating 
platelet adhesion and aggregation (13), and with delayed post-stress recovery in D-dimer 
levels, indicating prolonged intravascular fibrin formation (14). One study found increased 
stress reactivity of platelets in patients meeting clinical criteria for current MDD (15). As yet, 
there are no studies on stress-induced coagulation activation in patients with remitted MDD. 
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This knowledge could reveal whether the procoagulant stress response is a state or trait 
marker of MDD and may have implications for cardiovascular disease and prevention. 
Positive, adaptive coping strategies may attenuate the intensity and duration of the acute 
procoagulant stress response, whereas negative, maladaptive strategies seem less influential. In 
older dementia caregivers, greater levels of approach coping and planful problem-solving were 
both associated with lower D-dimer levels following a speech challenge and during post-stress 
recovery, whereas avoidant coping showed no relation with D-dimer levels (16). Healthy male 
subjects with greater adaptive anticipatory cognitive stress appraisal (e.g., less threat perception) 
showed less D-dimer formation in response to the Trier Social Stress Test (TSST) and during a 
post-stress recovery interval of one hour (17). When faced with general stress conditions, 
depressed individuals report less positive dispositional (trait) coping strategies, although 
more negative ones, than their non-depressed counterparts (18, 19). Whether situational (state) 
positive and negative coping strategies differ between depressed individuals and controls is to 
our knowledge unknown. However, as MI is being triggered by acute stress situations, 
studying the effects of stress-specific coping strategies on coagulation reactivity, as opposed 
to general ones, could yield deeper pathophysiologic insight. 
Our primary aim was to examine whether remitted MDD patients differ from healthy 
controls in mental stress-induced activation and post-stress recovery in fibrinogen, VWF, and 
D-dimer levels, and a sum score of these coagulation measures (prothrombotic index, PTI). 
Our secondary aim was to test the hypothesis that greater use of state positive coping is 
associated with less coagulation activation and to explore whether remitted MDD patients 
would differ from controls regarding such a stress-buffering effect. We also tested the 
tentative assumption (16) that negative state coping is less influential in affecting 




MATERIALS AND METHODS 
Study participants and recruitment 
This study was embedded in the second of two recruitment waves of a larger project 
investigating gene-environment effects on the laboratory stress response in remitted MDD 
(20). Results of the first recruitment wave have been reported elsewhere (19). Patients with 
remitted MDD and healthy controls were recruited from the longitudinal Early Developmental 
Stages of Psychopathology (EDSP) study, originally designed to investigate the prevalence, 
incidence, risk factors, course and comorbidity of mental disorders. In 1994, a random sample 
of 3,021 individuals aged 14 to 24 years of the city of Munich’s population register underwent 
the Munich-Composite International Diagnostic Interviews (M-CIDI) for the identification of 
DSM-IV psychiatric disorders (21). Four interviews were performed between 1995 and 2005 
with 2,210 subjects having participated in the final interview (22). We used the aggregated 
diagnostic information across all EDPS assessments resulting in 403 eligible subjects 
fulfilling the inclusion criteria as described below. From these subjects, 299 could be reached 
by telephone and were invited to participate in the laboratory stress test study. 139 refused 
participation for various reasons and further 29 subjects were excluded for medical reasons 
(severe medical disorder including ischemic heart disorder, cancer, endocrine disorders, 
medication with glucocorticoids, report of acute depressive symptoms). 131 subjects finally 
participated in the stress test study, with 66 recruited in the second recruitment wave. 
Coagulation activation as presented in here was measured only in the 66 participants of the 
second recruitment wave. 
Inclusion criteria for the remitted MDD patient group were a lifetime diagnosis of 
MDD and full remission of a MDD episode for at least six months. Lifetime diagnoses of a 
psychotic disorder, substance-abuse disorder, social phobia, bipolar affective disorder, 
dysthymia, needle-related anxiety, and medical conditions affecting coagulation activity were 
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exclusion criteria for all participants, but antidepressant use was not. For the healthy control 
group lifetime diagnoses of affective disorders and generalized anxiety disorder were 
additional exclusion criteria. The study personnel was kept blinded regarding the diagnostic 
information of the participants to ensure unbiased recruitment and study procedure for both 
groups. The ethics committee of the Ludwig-Maximilian University, Munich, Germany, 
approved the study protocol. All participants provided consent. 
 
Diagnostic assessment and measures 
Information on medication use, demographics, smoking history, and weight and height to 
calculate the body mass index (BMI) was obtained. All participants completed the German 
version of the 21-item Beck Depression Inventory (BDI)-II (23). Out of 66 recruited 
participants three had to be excluded, two because of depressive symptoms (BDI-II score ≥14; 
one from each group), and one healthy control with suspected acute infection based on a C-
reactive protein (CRP) level of 28.7 mg/L influencing coagulation. Hence, 63 participants, 40 
with remitted MDD and 23 controls were available for analysis. Further details on the study 
procedure have been published elsewhere (19, 20). 
 
Experimental procedure 
After arrival at the laboratory at 1:15 pm, participants were equipped with a pulse 
watch and chest belt (Polar©RS400) to measure heart rate (HR) as an index of stress-induced 
SNS activation. A venous catheter was placed into the vein of the non-dominant forearm 30 
min prior to collection of the baseline blood sample. To induce stress, we applied the widely 
used TSST (24) with an instruction and preparation phase of 10 minutes each, followed by a 
10-min public speaking task, involving a mock job interview and mental arithmetic. 
Participants watched a movie during a 45-min stress recovery phase. Blood samples for 
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coagulation measures were taken at baseline, and 15 min and 45 min post-stress. The TSST 
has been shown to provoke significant increases in plasma levels of coagulation factors, 
including fibrinogen, VWF, and D-dimer (14, 17, 25). 
About 30 min into the recovery phase from the TSST, all participants completed the 
84-item version of the German Stress Coping Inventory (“Stressverarbeitungsfragebogen”, 
SVF84-ak) (26). The questionnaire allows a retrospective self-assessment of coping strategies 
which were being used to deal with the preceding stressful situation. Participants were asked 
how likely coping-related thoughts came to their mind during the TSST such as “I try to 
control/antagonize my arousal”. Each item is rated on a Likert-scale from 0 (“not at all”) to 3 
(“certainly”). Four of the 84 items are summed up into 21 subscales, each, with missing items 
(less than 0.1%) replaced by the respective mean of the remaining items of a subscale. 
According to factor analysis, subscales can be clustered into one category with negative 
situational coping strategies, and one category with positive situational coping strategies. 
Negative coping comprises the subscales escape, social withdrawal, rumination, resignation, 
helplessness, self-pity, and self-blame (Cronbach alpha (α) =.92). Positive coping total 
(α=.90) can further be categorized into three categories termed (subscales in parentheses) 1) 
devaluation/defense (minimization, self-aggrandizement by comparison with others, denial of 
guilt; α=.80), 2) distraction (distraction, substitute gratification, search for self-affirmation, 
relaxation; α=.84), and 3) control (situation control, reaction control, positive self-
instructions; α=.85). Each category is calculated as the mean of the respective subscale 
scores. The total possible range of all subscale and category scores is between 0 and 12, each. 
 
Biochemical analyses 
Venous blood was collected into 0.3 mL citrate buffer tubes (Monovettes, Sarstedt, 
Nuremberg, Germany). Plasma concentrations of fibrinogen (lower limit of detection, LOD: 
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30 mg/dL) and VWF antigen (lower LOD: 270 mg/L) were determined with a multiplexed 
particle-based flow cytometric assay (Cytolab, Regensdorf, Switzerland). Plasma D-dimer 
concentration (lower LOD: 0 ng/mL) was determined with an enzyme-linked immunosorbent 
assay (Technozym D-dimer, Technoclone, Vienna, Austria). Inter- and intra-assay coefficients 
of variation were <15% for all analyses. CRP plasma levels were determined with the cobas 
6000 system (Roche Diagnostics, Switzerland). 
 
Data analysis 
Data were analyzed using SPSS statistics 25 (SPSS Inc., Chicago IL, USA) with 
significance level of p< 0.05 (two-tailed). Effect sizes are expressed as Cohen’s d where 0.2, 
0.5, and 0.8 reflect small, medium and large effects, respectively. Missing values for BDI-II-
scores (n=2), fibrinogen (n=2), VWF (n=5) and D-dimer (n=8) were replaced using the 
expectation maximization algorithm. D-dimer and CRP values were log transformed. Group 
differences in continuous and categorical data were calculated using independent samples t-
test and chi-square test, respectively. Bivariate relationships were estimated with Pearson 
correlation coefficients. Stress responses in coagulation measures and HR were analyzed 
using repeated measures analysis of variance with the Greenhouse-Geisser correction of 
degrees of freedom. Changes in biological variables over time were quantified (arbitrary 
units) with the area under the curve (AUC) with respect to baseline values (27). To calculate 
the PTI, our primary outcome variable, standardized z-scores of AUC values of fibrinogen, 
VWF and log D-dimer were added up, and the total was divided by three. In accordance with 
a systems biology approach (28), the PTI reflects an integrated estimate of prothrombotic 
function. Linear regression analysis, using forced entry, was employed to identify whether 
“group” (remitted MDD vs. healthy controls), negative and positive coping strategies, and the 
interaction terms between group and coping strategies were significantly linked with AUC of 
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coagulation measures. To guard against model overfitting, a maximum of four covariates 
(i.e., age, sex, BMI, current smoking) were selected a priori which could affect coagulation 
activity. Additional covariates were separately tested for potential influences. A sensitivity 
analysis was run excluding participants using a selective serotonin reuptake inhibitor (SSRI) 




As shown in Table 1, health characteristics were similar in both groups, except of a 
higher distraction score in patients with remitted MDD. Average levels of depressive 
symptoms were in the non-clinical range in both groups. Four participants took 
antidepressants, all an SSRI. 
 
Biological responses to acute stress 
Repeated measure ANOVA showed significant changes in HR (F=150, p<0.001, 
d=2.81) and in plasma levels of VWF (F=4.47, p=0.024, d=0.54) and D-dimer (F=7.53, 
p=0.002, d=0.70), but not in fibrinogen (p=0.20) across all participants. VWF and D-dimer 
levels were higher than baseline 15 min and 45 min post-stress (all p-values ≤ 0.42). There 
were no significant group-by-time interactions for HR (p=0.19), fibrinogen (p=0.60), VWF 
(p=0.76) and D-dimer (p=0.25). In Table 2, mean values for HR and coagulation factors 
across time points are depicted for each group. 
 
Remitted depression, coping and stress-induced coagulation activation over time 
As can be seen in Table 3, unlike positive coping total, negative coping showed no 
significant associations with coagulation measures in the unadjusted analyses (Model 1b), the 
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analyses adjusted for age, sex, BMI, and smoking (Model 2a), and in the adjusted moderator 
analyses (Model 3a). The non-significant results for negative coping were confirmed in a 
sensitivity analysis, excluding the four participants with SSRI use. 
Higher positive coping total was associated with lower change in PTI AUC in the 
adjusted analysis (p=0.009, d=0.73; Model 2b) in all participants. A significant group-by-
positive coping total interaction emerged for VWF AUC (p=0.002, d=0.87, Model 3b) such 
that higher positive coping total was significantly associated with lower VWF AUC in 
healthy controls (B=-0.494, 95% CI: -0.842, -0.146, p=0.008, d=1.45), but not in remitted 
MDD patients (B=-0.018, 95% CI: -0.179, 0.144, p=0.83, d=0.08). In the latter, additional 
adjustment for time since the last depressive episode did not change this association (p=0.97). 
In a sensitivity analysis, excluding participants using an SSRI, the significance of the 
relationship between positive coping total and PTI AUC (p=0.019) and of the group-by-
positive coping total interaction for VWF AUC (p=0.18) were both maintained. Further 
complementary analyses were performed to examine potentially confounding effects of 
additional variables. The significance of the above results for positive coping total was 
maintained when either negative coping, HR AUC, oral contraceptive use, CRP levels, 
residual depressive symptoms or the number of previous MDD episodes were additionally 
adjusted for, each separately so to limit the risk of model overfitting. 
  
Associations with subscales of positive coping 
To specify the characteristics of positive coping being associated with the above 
reported stress-induced coagulation activation, we modelled separate analyses for each 
positive coping subscale. All subscales showed an inverse association, reaching significance 
for devaluation/defense and distraction, with PTI AUC in all participants and with VWF 




This study examined acute stress-induced coagulation activation along with a 
potentially modulating role of stress-specific coping strategies in patients with remitted MDD 
and healthy controls. Across all participants, corroborating previous studies (13, 14, 16, 17, 
25), plasma levels of VWF and D-dimer, although not fibrinogen, showed a significant stress 
response, remaining higher than at baseline during a post-stress recovery interval of 45 min. 
This is within the critical time interval during which the risk of MI onset increases following 
emotional upset (29). However, coagulation responses over time were not significantly 
different between patients with remitted MDD and healthy controls, even when considering 
potentially confounding effects of a range of variables that could affect coagulation. This 
observation contrasts with several previous studies showing significant relationships between 
current depressed mood severity and stress-induced coagulation changes (12-15). Therefore, 
it is arguably the chronic trait factor of current depression which might critically underlie 
prothrombotic stress reactivity.  
Across all study participants, we found that greater levels of situational positive 
coping total, significantly driven by positive devaluation/defense and distraction coping, was 
associated with less pronounced coagulation activation over time measured by a PTI. The 
same significant associations were found for lower changes in VWF over time in healthy 
controls, but not in remitted MDD patients. All associations showed moderate to large effect 
sizes, suggesting that the absence of positive situational coping strategies could have clinical 
implications such as for coagulation mechanisms involved in stress-triggered MI. By and large, 
this novel finding is consistent with the general view that positive dispositional coping 
strategies are adaptive, alleviate stress, and thus provide health benefits. In this regard, 
healthy controls seemed to benefit more from positive state coping effects on VWF reactivity 
than patients with remitted MDD. This finding is particularly intriguing given that remitted 
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MDD patients reported significantly greater use of positive distraction coping in dealing with the 
TSST than controls. Impaired endothelial function in patients with remitted MDD (30) could be 
one explanation for a group difference in VWF reactivity, but not in fibrinogen and D-dimer 
reactivity. Unlike fibrinogen and D-dimer, VWF is released from endothelial cells into circulation 
in response to stress and impaired endothelial function is associated with excess VWF release (10). 
However, the mechanisms and implications of this group difference for cardiovascular health 
outcomes were not examined and therefore remain speculative. Similar to a previous study 
(16), stress-specific negative coping was not associated with coagulation reactivity.  
Besides the lack of a comparison group with current MDD, the possibility of residual 
confounding due to unmeasured lifestyle and subclinical atherosclerosis, lacking information on 
psychotherapy treatment, and limited statistical power, the interpretation of our findings should 
consider several limitations. We measured coagulation factors 15 min into the post-stress recovery 
period, instead of immediately after stress, which could help to explain the lack of both a stress 
response in fibrinogen and an association of positive coping with fibrinogen and D-dimer. In 
contrast, VWF is arguably among the most responsive hemostatic factors to sympathetic activation 
and stress (10). Although depressed individuals exhibit greater moment-to-moment variability and 
daily life-event-related stress reactivity in negative affect (31, 32), it is as yet unknown whether 
they also run a higher risk of incident MI with emotional triggers than their non-depressed 
counterparts. Whether biological responses like coagulation changes to the TSST can be translated 
to real life stress situations is a matter of debate. Additional assessment of stress responses in 
platelets, clotting factor VIII and fibrinolysis had yielded a more comprehensive picture of 
hemostatic changes to stress (10). 
Taken together, remitted MDD patients did not differ in stress-induced coagulation 
responses from healthy controls. Positive stress-specific coping strategies may mitigate stress-
induced coagulation activation, and this effect seemed less pronounced in patients with remitted 
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MDD regarding VWF reactivity. Implications for the prevention of stress-triggered MI could 
comprise adopting positive state coping in patients at risk of cardiovascular disease, including 
those with a lifetime history of MDD. 
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Table 1. Characteristics of the 63 study participants 





Age, years 34.7 (3.5) 36.1 (3.6) 0.128 
Female sex, n 23 (57.5) 14 (65.2) 0.794 
Oral contraceptives, n 7 (17.5) 6 (26.1) 0.522 
Selective serotonin reuptake inhibitors, n 2 (5.0) 2 (8.7) 0.465 
Body mass index, kg/m2 23.9 (2.9) 23.7 (2.4) 0.797 
Current smoker, n 8 (20.0) 5 (21.7) 1.000 
C-reactive protein, mg/L 2.24 (2.48) 1.98 (1.98) 0.728 
Age of depression onset, years 19.2 (4.4) n.a. n.a. 
Time since last depressive episode, years 10.6 (6.3) n.a. n.a. 
Previous depressive episodes, n 3.3 (3.3) 0 <0.001 
BDI-II symptoms, score 2.0 (2.8) 2.0 (3.3) 0.968 
Negative coping, score 1.4 (1.6) 1.2 (1.3) 0.659 
Positive coping total, score 3.6 (1.8) 3.5 (1.7) 0.676 
Positive coping devaluation/defense, score 3.0 (1.6) 3.0 (2.0) 0.985 
Positive coping distraction from stress, score 3.1 (1.9) 2.1 (1.5) 0.030 
Positive coping control, score 4.8 (2.6) 5.3 (2.6) 0.526 
 
Values are means with standard deviation or percentages in parentheses 






Table 2. Heart rate and coagulation factor values at assessed time points per study group 
Time Heart rate (bpm) Fibrinogen (mg/dL) von Willebrand factor (mg/L) Log D-dimer (ng/mL) 
 Remitted MDD Controls Remitted MDD Controls Remitted MDD Controls Remitted MDD Controls 
Baseline 80.6 (2.0) 79.1 (2.4) 126.5 (3.6) 108.0 (5.3) 11.9 (0.6) 11.6 (1.5) 1.19 (0.14) 1.12 (0.19) 
Post-instruction 81.4 (1.9) 82.4 (2.7)       
Pre-stress 96.6 (2.3) 100.1 (2.3)       
Post-stress 98.3 (2.2) 102.5 (3.1)       
+15 min 76.6 (1.4) 76.6 (2.4) 120.4 (4.2) 107.0 (7.8) 13.6 (0.7) 12.5 (1.1) 1.55 (0.09) 1.57 (0.17) 
+30 min 74.2 (1.6) 75.3 (2.1)       
+45 min 75.4 (1.6) 73.0 (2.1) 119.1 (4.1) 106.7 (6.6) 13.7 (0.7) 12.6 (0.8) 1.35 (0.09) 1.39 (0.16) 
 
Values are means (original values) with standard error of the mean in parentheses. There was no significant group-by-time interaction for any 








Table 3. Relations between remitted MDD, negative coping, positive coping total and stress-induced coagulation activation over time 
Model Variables entered PTI AUC Fibrinogen AUC VWF AUC D-dimer AUC 
1a Remitted MDD -0.062 (-0.366, 0.242) -0.229 (-0.754, 0.295) 0.146 (-0.380, 0.672) -0.102 (-0.629, 0.424) 
1b Negative coping -0.025 (-0.122, 0.072) -0.046 (-0.214, 0.121) -0.091 (-0.258, 0.075) 0.063 (-0.104, 0.230) 
1c Positive coping total -0.079 (-0.161, 0.004) -0.121 (-0.265, 0.023) -0.144 (-0.287, -0.001)* 0.028 (-0.119, 0.175) 
2a Remitted MDD 
Negative coping 
-0.135 (-0.435, 0.165) 
-0.083 (-0.187, 0.020) 
-0.293 (-0.827, 0.240) 
-0.102 (-0.285, 0.082) 
0.076 (-0.454, 0.605) 
-0.166 (-0.348, 0.016) 
-0.187 (-0.699, 0.324) 
0.017 (-0.159, 0.193) 
2b Remitted MDD 
Positive coping total 
-0.123 (-0.412, 0.166) 
-0.114 (-0.198, -0.030)** 
-0.280 (-0.807, 0.247) 
-0.123 (-0.276, 0.030) 
0.094 (-0.428, 0.617) 
-0.169 (-0.321, -0.017)* 
-0.184 (-0.694, 0.325) 
-0.050 (-0.198, 0.099) 
3a Remitted MDD 
Negative coping 
Remitted MDD x 
negative coping 
-0.045 (-0.454, 0.364) 
-0.030 (-0.224, 0.163) 
-0.071 (-0.287, 0.146) 
0.065 (-0.651, 0.780) 
0.110 (-0.228, 0.448) 
-0.281 (-0.660, 0.098) 
-0.025 (-0.748, 0.698) 
-0.225 (-0.567, 0.116) 
0.079 (-0.304, 0.462) 
-0.175 (-0.875, 0.525) 
0.024 (-0.306, 0.355) 
-0.009 (-0.380, 0.361) 
3b Remitted MDD 
Positive coping total 
Remitted MDD x 
positive coping total 
-0.502 (-1.160, 0.157) 
-0.186 (-0.327, -0.045)* 
0.109 (-0.061, 0.279) 
0.100 (-1.114, 1.314) 
-0.051 (-0.310, 0.209) 
-0.109 (-0.423, 0.205) 
-1.509 (-2.617, -0.401)** 
-0.475 (-0.711, -0.238)*** 
0.461 (0.174, 0.747)** 
-0.096 (-1.275, 1.082) 
-0.033 (-0.284, 0.219) 
-0.025 (-0.330, 0.279) 
Values are unstandardized beta-coefficients (B) of z-scores with 95% confidence interval. Model 1 shows zero-order correlations. Models 2 and 
3 were both adjusted for age, sex, body mass index and smoking. Significance level: * p<0.05, ** P<0.01, *** P<0.001. 




Table 4. Associations of stress-induced coagulation activation with subscales of positive coping 
 Devaluation/defense Distraction  Control 
 B (95% CI) p d B (95 % CI p d B (95% CI) p d 
PTI AUC -0.110 (-0.203, -0.017) 0.022 0.63 -0.123 (-0.204, -0.041) 0.004 0.80 -0.055 (-0.113, 0.003) 0.063 0.51 
VWF AUC          
Group x subscale 0.328 (0.045, 0.611) 0.024 0.63 0.479 (0.156, 0.802) 0.004 0.80 0.255 (0.056, 0.455) 0.013 0.69 
Remitted MDD -0.016 (-0.210, 0.178) 0.867 0.06 -0.006 (-0.160, 0.148) 0.940 0.03 -0.015 (-0.122, 0.091) 0.771 0.10 
Controls -0.455 (-0.784, -0.126) 0.010 1.41 -0.475 (-0.875, -0.074) 0.023 1.21 -0.250 (-0.507, 0.006) 0.055 0.45 
All analyses were adjusted for age, sex, body mass index and smoking. 
AUC, area under the curve; MDD, major depressive disorder; PTI, prothrombotic index; VWF, von Willebrand Factor 
